Prot #ADU-CL-11: A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination with Epacadostat in Adults with Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date7/19/16 → 7/19/19

Funding

  • Medpace, Inc. (Prot #ADU-CL-11 // Prot #ADU-CL-11)
  • Aduro Biotech, Inc (Prot #ADU-CL-11 // Prot #ADU-CL-11)